Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity.

Totary-Jain H, Sionov RV, Gallily R.

Immunol Lett. 2016 Aug;176:1-7. doi: 10.1016/j.imlet.2016.05.011. Epub 2016 May 17.

2.

In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, Peshes-Yaloz N, Castiel A, Waldman D, Gallily R, Mechoulam R, Toren A.

Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16.

3.

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid.

Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R.

J Pharmacol Exp Ther. 2015 Oct;355(1):66-75. doi: 10.1124/jpet.115.226100. Epub 2015 Aug 13.

4.

Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.

Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R, Lavie G, Amariglio N, Rechavi G, Toren A.

Acta Oncol. 2008;47(6):1062-70.

PMID:
17934890
5.

Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.

Durst R, Danenberg H, Gallily R, Mechoulam R, Meir K, Grad E, Beeri R, Pugatsch T, Tarsish E, Lotan C.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3602-7. Epub 2007 Sep 21.

6.

Cannabidiol arrests onset of autoimmune diabetes in NOD mice.

Weiss L, Zeira M, Reich S, Slavin S, Raz I, Mechoulam R, Gallily R.

Neuropharmacology. 2008 Jan;54(1):244-9. Epub 2007 Jul 17.

7.
8.

Cannabidiol lowers incidence of diabetes in non-obese diabetic mice.

Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R.

Autoimmunity. 2006 Mar;39(2):143-51.

PMID:
16698671
9.

A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.

Kogan NM, Blázquez C, Alvarez L, Gallily R, Schlesinger M, Guzmán M, Mechoulam R.

Mol Pharmacol. 2006 Jul;70(1):51-9. Epub 2006 Mar 29.

10.

N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.

Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, Mo FM, Offertaler L, Pacher P, Kunos G, Mechoulam R.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2428-33. Epub 2006 Feb 7.

11.

New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity.

Ben-Shabat S, Hanus LO, Katzavian G, Gallily R.

J Med Chem. 2006 Feb 9;49(3):1113-7.

PMID:
16451075
12.

The Jerusalem Balsam: from the Franciscan Monastery in the old city of Jerusalem to Martindale 33.

Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, Mechoulam R.

J Ethnopharmacol. 2005 Oct 3;101(1-3):16-26.

PMID:
15963667
13.

Dorzolamide-induced choroidal detachment in a surgically untreated eye.

Goldberg S, Gallily R, Bishara S, Blumenthal EZ.

Am J Ophthalmol. 2004 Aug;138(2):285-6.

PMID:
15289139
14.

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.

Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M.

Arthritis Rheum. 2004 Mar;50(3):985-98.

15.

Gamma-irradiation enhances apoptosis induced by cannabidiol, a non-psychotropic cannabinoid, in cultured HL-60 myeloblastic leukemia cells.

Gallily R, Even-Chena T, Katzavian G, Lehmann D, Dagan A, Mechoulam R.

Leuk Lymphoma. 2003 Oct;44(10):1767-73.

PMID:
14692532
16.

Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model.

Lodzki M, Godin B, Rakou L, Mechoulam R, Gallily R, Touitou E.

J Control Release. 2003 Dec 12;93(3):377-87.

PMID:
14644587
17.

Cannabidiol: an overview of some pharmacological aspects.

Mechoulam R, Parker LA, Gallily R.

J Clin Pharmacol. 2002 Nov;42(S1):11S-19S. Review.

PMID:
12412831
18.

Effect of Mycoplasma fermentans on brain PGE(2): role of glucocorticoids and their receptors.

Wohlman A, Yirmiya R, Gallily R, Weidenfeld J.

Neuroimmunomodulation. 2001;9(3):141-7.

PMID:
11752887
19.

Inhibition of nitric oxide production for down-regulation of CNS inflammation and demyelination.

Brenner T, Pinto F, Abramsky O, Gallily R.

Prog Brain Res. 2001;132:499-506. Review. No abstract available.

PMID:
11545014
20.
21.

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.

Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M.

Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6.

22.
23.

Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat.

Trembovler V, Beit-Yannai E, Younis F, Gallily R, Horowitz M, Shohami E.

J Interferon Cytokine Res. 1999 Jul;19(7):791-5.

PMID:
10454350
24.

The role of brain cytokines in mediating the behavioral and neuroendocrine effects of intracerebral mycoplasma fermentans.

Yirmiya R, Weidenfeld J, Barak O, Avitsur R, Pollak Y, Gallily R, Wohlman A, Ovadia H, Ben-Hur T.

Brain Res. 1999 May 22;829(1-2):28-38.

PMID:
10350527
25.
26.

Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation.

Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S, Garzotto M, McLoughlin M, Gallily R, Edwards CK 3rd, Schuchman EH, Fuks Z, Kolesnick R.

J Exp Med. 1997 Dec 1;186(11):1831-41.

27.

Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.

Gallily R, Yamin A, Waksmann Y, Ovadia H, Weidenfeld J, Bar-Joseph A, Biegon A, Mechoulam R, Shohami E.

J Pharmacol Exp Ther. 1997 Nov;283(2):918-24.

28.

Characterization of the effect of Mycoplasma fermentans on the hypothalamo-pituitary-adrenal axis.

Wohlman A, Gallily R, Yirmiya R, Weidenfeld J.

Neuroendocrinology. 1997 Sep;66(3):221-8.

PMID:
9380280
29.

Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis.

Engelhard D, Pomeranz S, Gallily R, Strauss N, Tuomanen E.

J Infect Dis. 1997 Apr;175(4):979-82.

PMID:
9086164
30.

Intracerebral administration of Mycoplasma fermentans produces sickness behavior: role of prostaglandins.

Yirmiya R, Barak O, Avitsur R, Gallily R, Weidenfeld J.

Brain Res. 1997 Feb 21;749(1):71-81.

PMID:
9070629
31.

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant.

Shohami E, Gallily R, Mechoulam R, Bass R, Ben-Hur T.

J Neuroimmunol. 1997 Feb;72(2):169-77. Review.

PMID:
9042110
32.

Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury.

Shohami E, Bass R, Wallach D, Yamin A, Gallily R.

J Cereb Blood Flow Metab. 1996 May;16(3):378-84.

PMID:
8621742
33.

Identification and characterization of a novel protein associated with macrophage complement receptor 3.

Messika EJ, Avni O, Gallily R, Yefenof E, Baniyash M.

J Immunol. 1995 Jun 15;154(12):6563-70.

PMID:
7759890
34.

Mycoplasma fermentans activates the hypothalamo-pituitary adrenal axis in the rat.

Weidenfeld J, Wohlman A, Gallily R.

Neuroreport. 1995 Apr 19;6(6):910-2.

PMID:
7612881
35.

Pasteurella multocida toxin induces IL-6, but not IL-1 alpha or TNF alpha in fibroblasts.

Rosendal S, Frandsen PL, Nielsen JP, Gallily R.

Can J Vet Res. 1995 Apr;59(2):154-6.

36.
37.

Cytokines induced in vitro by Mycoplasma mycoides ssp. mycoides, large colony type.

Rosendal S, Levisohn S, Gallily R.

Vet Immunol Immunopathol. 1995 Feb;44(3-4):269-78.

PMID:
7747406
38.

Differential H-2 antigen expression in teratocarcinoma-fibroblast hybrids.

Sionov RV, Gallily R.

Exp Clin Immunogenet. 1995;12(4):238-44.

PMID:
8919356
39.

Characterization and purification of a mycoplasma membrane-derived macrophage-activating factor.

Caplan S, Gallily R, Barenholz Y.

Cancer Immunol Immunother. 1994 Jul;39(1):27-33.

PMID:
8044823
40.

Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue.

Shohami E, Novikov M, Bass R, Yamin A, Gallily R.

J Cereb Blood Flow Metab. 1994 Jul;14(4):615-9.

PMID:
8014208
41.
42.

Trophoblasts protect the inner cell mass from macrophage destruction.

Sionov RV, Yagel S, Har-Nir R, Gallily R.

Biol Reprod. 1993 Sep;49(3):588-95.

PMID:
7691193
43.
44.

Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide.

Pappo I, Bercovier H, Berry EM, Haviv Y, Gallily R, Freund HR.

JPEN J Parenter Enteral Nutr. 1992 Nov-Dec;16(6):529-32.

PMID:
1494209
45.
47.
48.

Thymocyte maturation following interaction with thymus-derived macrophages.

Zeira M, Gallily R, Stein I, Giloh H.

Cell Immunol. 1991 May;134(2):370-7.

PMID:
1673640
49.

Partial biochemical characterization of spiroplasma membrane component inducing tumor necrosis factor alpha.

Sher T, Yamin A, Matzliach M, Rottem S, Gallily R.

Anticancer Drugs. 1990 Oct;1(1):83-7.

PMID:
2131043
50.

In vitro induction of tumor necrosis factor alpha, tumor cytolysis, and blast transformation by Spiroplasma membranes.

Sher T, Yamin A, Rottem S, Gallily R.

J Natl Cancer Inst. 1990 Jul 4;82(13):1142-5.

PMID:
2359139

Supplemental Content

Loading ...
Support Center